LMT's total sales in the fourth quarter of 2024 miss the Zacks Consensus Estimate by 1.2%. The top line also decreases 1.3% from the year-ago level.

RTX's Q4 sales of $21.62 billion surpass the Zacks Consensus Estimate by 5.2%. The metric also surges a solid 8.5% from the prior-year level.

CMS' fourth-quarter revenues miss the Zacks Consensus Estimate by 7.1%. However, the top line increases 2% from the year-ago level.

BA's Q4 revenues amount to $15.24 billion, which beat the Zacks Consensus Estimate by 0.4% and decrease 31% from the year-ago quarter's level.

BAH's third-quarter fiscal 2025 earnings and revenues increase year over.

GD's Q4 revenues of $13.34 billion beat the Zacks Consensus Estimate by 2.1% and also improve 14.3% from the prior-year figure.

The Zacks Consensus Estimate for TM's fiscal third-quarter earnings and revenues is pegged at $4.36 per share and $78.36 billion, respectively.

ENS' fiscal Q3 net sales increase 5.2% driven by the impressive performance of its operating segments.

EAT's second-quarter fiscal 2025 top line indicates favorable comparable restaurant sales, driven by menu pricing, higher traffic and a favorable menu...

Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.